Ranitidine hydrochloride and Carbamazepine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ranitidine hydrochloride (ranitidine hydrochloride) and Carbamazepine (carbamazepine). Common drug interactions include renal failure among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Ranitidine hydrochloride and Carbamazepine. It is created by eHealthMe based on reports of 81 people who take the same drugs from the FDA, and is updated regularly.

What is Ranitidine hydrochloride?

Ranitidine hydrochloride has active ingredients of ranitidine hydrochloride. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 76,413 Ranitidine hydrochloride users. Check the latest studies of Ranitidine hydrochloride.

What is Carbamazepine?

Carbamazepine has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 44,628 Carbamazepine users. Check the latest studies of Carbamazepine.



On Jul, 06, 2026

81 people who take Ranitidine hydrochloride and Carbamazepine together, and have interactions are studied.

Ranitidine hydrochloride and Carbamazepine drug interactions.

What are the common drug interactions of Ranitidine Hydrochloride and Carbamazepine, by gender? *:

female:

  1. Renal failure (kidney dysfunction)
  2. Sensory loss (senses loss)
  3. Vomiting
  4. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  5. Blood creatine phosphokinase increased
  6. Conjunctivitis (pink eye)
  7. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  8. Dizziness
  9. Drug ineffective
  10. Erythema (redness of the skin)

male:

  1. Chronic kidney disease
  2. Lung neoplasm malignant (cancer tumour of lung)
  3. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  4. Lymphadenopathy (disease or enlargement of lymph nodes)
  5. Malignant neoplasm progression (cancer tumour came back)
  6. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  7. Pain in extremity
  8. Pneumonia
  9. Skin desquamation (loss of the upper layers of skin)
  10. Aggression

What are the common drug interactions of Ranitidine Hydrochloride and Carbamazepine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

  1. Hepatic failure (liver failure)
  2. Apnoea (suspension of external breathing)
  3. Blood bilirubin increased
  4. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  5. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  6. Irritability
  7. Pneumonitis aspiration (acute lung injury after the inhalation of regurgitated gastric contents)
  8. Pyrexia (fever)
  9. Sweating increased (excess sweating)
  10. Thrombocytopenia (decrease of platelets in blood)

10-19:

n/a

20-29:

  1. Blood creatine phosphokinase increased
  2. Myoglobinuria (presence of myoglobin in the urine)
  3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
  4. Body temperature increased
  5. Muscle twitching
  6. Abdominal pain
  7. Anaphylactic reaction (serious allergic reaction)
  8. Anxiety
  9. Drug hypersensitivity
  10. Encephalitis (inflammation of the brain)

30-39:

  1. Chronic kidney disease
  2. Cardiac disorder
  3. Lung disorder (lung disease)
  4. Dysgeusia (disorder of the sense of taste)
  5. Impaired gastric emptying
  6. Post procedural complication
  7. Urinary retention (the inability to completely or partially empty the bladder)

40-49:

  1. Chronic kidney disease
  2. Decreased appetite
  3. Fatigue (feeling of tiredness)
  4. Nausea (feeling of having an urge to vomit)
  5. Renal failure (kidney dysfunction)
  6. Vomiting
  7. Abdominal distension
  8. Aggression
  9. Asthenia (weakness)
  10. Bone metabolism disorder

50-59:

  1. Haematemesis (vomiting of blood)
  2. Head injury
  3. Headache (pain in head)
  4. Hypochloraemia (electrolyte disturbance in which there is an abnormally low level of the chloride ion in the blood)
  5. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  6. Lung neoplasm malignant (cancer tumour of lung)
  7. Muscle spasms (muscle contraction)
  8. Myocardial rupture (damage to heart muscle ,tearing of the walls of the ventricles or atria of the heart)
  9. Nausea (feeling of having an urge to vomit)
  10. Neoplasm malignant (cancer tumour)

60+:

  1. Pyrexia (fever)
  2. Rigors (an episode of shaking or exaggerated shivering)
  3. Lip erosion (peeling off of lip)
  4. Lymphadenopathy (disease or enlargement of lymph nodes)
  5. Mucosal erosion (peeling off of mucous membrane)
  6. Pruritus generalised (generalized itching)
  7. Rash macular (small, flat red spots)
  8. Shivering
  9. Skin desquamation (loss of the upper layers of skin)
  10. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)

What are the existing conditions these people have? *

  1. Pain: 9 people, 11.11%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 8.64%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 8.64%
  4. High Blood Pressure: 6 people, 7.41%
  5. Gastric Ulcer (stomach ulcer): 5 people, 6.17%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine hydrochloride and Carbamazepine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ranitidine hydrochloride and Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ranitidine hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Carbamazepine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ranitidine hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Carbamazepine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on ranitidine hydrochloride and carbamazepine (the active ingredients of Ranitidine hydrochloride and Carbamazepine, respectively), and Ranitidine hydrochloride and Carbamazepine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: